Autres langues Decoy Therapeutics Inc.

Actions

DCOY

US79400X5032

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 13/02/2026			Varia. 5j.	Varia. 1 janv.
0,7388 ^USD	-1,51%		-5,27%	+13,87%

11/02	Decoy Therapeutics rejoint la plateforme Webull Corporate Connect Service	CI
23/01	DECOY THERAPEUTICS INC. : Ladenburg Thalmann maintient sa recommandation à l'achat	ZM

Autres langues

11/02	Decoy Therapeutics Joins Webull Corporate Connect Service Platform
11/02	Decoy Therapeutics Joins Webull Corporate Connect Service Platform
05/02	Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
04/02	Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement
13/01	Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of A Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
13/01	Decoy Therapeutics reaches global access commitment agreement to focus on development of a globally accessible, scalable peptide-conjugate manufacturing platform
13/01	Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
08/01	Salarius Pharmaceuticals, Inc. will Change its Ticker to DCOY from SLRX
08/01	Salarius Pharmaceuticals, Inc. will Change its Name to Decoy Therapeutics Inc
07/01	Salarius Pharmaceuticals changes name to Decoy Therapeutics
07/01	Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics
05/01	Top Midday Decliners
19/12	Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
18/12	Salarius Pharmaceuticals to Change Name to Decoy Therapeutics
18/12	Salarius Pharmaceuticals announces name and ticker change to Decoy Therapeutics
18/12	Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
01/12	Salarius Pharmaceuticals' Decoy Unit Partners With Texas Biomed on Flu Inhibitor Testing
01/12	Salarius Pharmaceuticals to collaborate with Texas Biomedical Research Institute on avian flu study
01/12	Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
20/11	Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol SLRX
19/11	Salarius Pharmaceuticals Says S&P Capital IQ Platform Misreported Nasdaq Status After Merger
19/11	Salarius Pharmaceuticals : Cites Errors on S&P CapIQ...
19/11	Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
14/11	Salarius: Q3 Earnings Snapshot
14/11	Decoy Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse Idées de trading

Autres langues Decoy Therapeutics Inc.

Actions

DCOY

US79400X5032

Recherche biotechnologique et médicale

Autres langues

Filtres